This section provides information on the European Medicines Agency's activities relating to paediatric medicines during the post-authorisation stage.
- Annual reports on deferrals
- Deadlines for placing paediatric medicines on the market
- Paediatric requirements for variations and extensions to marketing authoriations
- Submitting results of paediatric studies
How useful is this page?
Average rating:Based on 3 ratings
Add your rating:
- See all ratings
2 ratings0 ratings0 ratings0 ratings1 ratings
- Better medicines for children (2015-05-18)